Indiva Net debt/EBITDA
Qual é o Net debt/EBITDA de Indiva?
O Net debt/EBITDA de Indiva Ltd. é -13.08
Qual é a definição de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA de empresas na Setor Health Care em TSXV em comparação com Indiva
O que Indiva faz?
Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Empresas com net debt/ebitda semelhantes a Indiva
- ECO Animal Health plc tem Net debt/EBITDA de -13.13
- Global Sweeteners tem Net debt/EBITDA de -13.12
- Taylor Devices tem Net debt/EBITDA de -13.09
- OSE Immunotherapeutics SA tem Net debt/EBITDA de -13.09
- Kamada Ltd tem Net debt/EBITDA de -13.09
- AM tem Net debt/EBITDA de -13.09
- Indiva tem Net debt/EBITDA de -13.08
- Echelon tem Net debt/EBITDA de -13.07
- Inseego tem Net debt/EBITDA de -13.05
- Cipher Pharmaceuticals tem Net debt/EBITDA de -13.05
- IXICO plc tem Net debt/EBITDA de -13.03
- Altair Engineering Inc tem Net debt/EBITDA de -13.00
- Avio S.p.A tem Net debt/EBITDA de -13.00